Malaria--a shadow over Africa.
Reduction in severe disease and death from falciparum malaria in Africa requires new, more effective and inexpensive public health measures. The completed genomes of Plasmodium falciparum and its vector Anopheles gambiae represent a big step toward the discovery of these needed tools.
D017954:Africa South of the Sahara / Q000453:epidemiology; D000818:Animals; D000852:Anopheles / Q000235:genetics / Q000469:parasitology / Q000502:physiology; D000962:Antimalarials / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D019353:Endemic Diseases; D005247:Feeding Behavior; D016678:Genome; D018503:Genome, Protozoan; D006801:Humans; D007299:Insect Bites and Stings; D007303:Insect Vectors / Q000235:genetics / Q000469:parasitology / Q000502:physiology; D008288:Malaria / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D017780:Malaria Vaccines; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D009032:Mosquito Control; D010963:Plasmodium falciparum / Q000187:drug effects / Q000235:genetics / Q000254:growth & development; D017422:Sequence Analysis, DNA; D013696:Temperature
D000962:Antimalarials; D017780:Malaria Vaccines